Title:
【発明の名称】特定のアルキレンジアミンで置換された複素環
Document Type and Number:
Japanese Patent JP2003510327
Kind Code:
A
Abstract:
This invention relates to novel compounds, compositions, and methods for the treatment of physiological disorders associated with an excess of neuropeptide Y. The novel compounds encompassed by the present invention are those of the formula II, IV, V, VII-IX and XI
Inventors:
Hovath, Raymond F
Tran, Jennifer
De Lombard, Stephan
Hodgets, Kevin Julian
Carpino, Philip A.
Griffith, David A
Tran, Jennifer
De Lombard, Stephan
Hodgets, Kevin Julian
Carpino, Philip A.
Griffith, David A
Application Number:
JP2001526541A
Publication Date:
March 18, 2003
Filing Date:
September 29, 2000
Export Citation:
Assignee:
Neurogen Corporation
Pfizer Inc.
Pfizer Inc.
International Classes:
A61K31/437; A61K31/4375; A61K31/4409; A61K31/4706; A61K31/505; A61K31/519; A61K31/522; A61P1/12; A61P3/04; A61P3/06; A61P3/10; A61P5/06; A61P5/48; A61P7/04; A61P9/00; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P11/02; A61P11/06; A61P13/12; A61P15/00; A61P15/10; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P29/00; A61P43/00; C07D213/73; C07D213/74; C07D215/46; C07D239/48; C07D471/04; C07D471/14; C07D473/34; C07D475/06; C07D475/08; C07D487/04; C07D495/04; (IPC1-7): C07D213/74; A61K31/437; A61K31/4375; A61K31/4409; A61K31/4706; A61K31/505; A61K31/519; A61K31/522; A61P1/12; A61P3/04; A61P3/06; A61P3/10; A61P5/06; A61P5/48; A61P7/04; A61P9/00; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P11/02; A61P11/06; A61P13/12; A61P15/00; A61P25/04; A61P25/06; A61P25/08; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P29/00; A61P43/00; C07D215/46; C07D239/48; C07D471/04; C07D471/14; C07D473/34; C07D475/06; C07D487/04; C07D495/04
Domestic Patent References:
| JPH07509726A | 1995-10-26 | |||
| JPH09507249A | 1997-07-22 | |||
| JPH09504520A | 1997-05-06 |
Foreign References:
| US2465568A | 1949-03-29 | |||
| WO1999040091A1 | 1999-08-12 | |||
| WO1994013677A1 | 1994-06-23 | |||
| WO1998029397A1 | 1998-07-09 | |||
| WO1998035967A2 | 1998-08-20 | |||
| WO1998008846A1 | 1998-03-05 | |||
| EP0773023A1 | 1997-05-14 | |||
| WO1997035580A1 | 1997-10-02 | |||
| WO1997029110A1 | 1997-08-14 | |||
| WO1999045007A1 | 1999-09-10 | |||
| WO1997044038A1 | 1997-11-27 | |||
| GB587550A | 1947-04-29 | |||
| US2437683A | 1948-03-16 |
Other References:
THE JOURNAL OF ORGANIC CHEMISTRY, vol. 23, no. 2, JPN4006016306, 1958, pages 191 - 200, ISSN: 0000769892
JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, no. 5, JPN4006016307, March 1999 (1999-03-01), pages 833 - 848, ISSN: 0000769893
THE JOURNAL OF ORGANIC CHEMISTRY, vol. 23, no. 2, JPNX007021693, 1958, pages 191 - 200, ISSN: 0000842618
JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, no. 5, JPNX007021694, March 1999 (1999-03-01), pages 833 - 848, ISSN: 0000842619
JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, no. 5, JPN4006016307, March 1999 (1999-03-01), pages 833 - 848, ISSN: 0000769893
THE JOURNAL OF ORGANIC CHEMISTRY, vol. 23, no. 2, JPNX007021693, 1958, pages 191 - 200, ISSN: 0000842618
JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, no. 5, JPNX007021694, March 1999 (1999-03-01), pages 833 - 848, ISSN: 0000842619
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)